OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients
Sonja Johann, Marius Heitzer, Mithila Kanagaratnam, et al.
Glia (2015) Vol. 63, Iss. 12, pp. 2260-2273
Closed Access | Times Cited: 240

Showing 1-25 of 240 citing articles:

Ageing as a risk factor for neurodegenerative disease
Yujun Hou, Xiuli Dan, Mansi Babbar, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 10, pp. 565-581
Closed Access | Times Cited: 2418

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon, Seong‐Ho Koh
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 1686

Inflammasome signalling in brain function and neurodegenerative disease
Michael T. Heneka, Róisín M. McManus, Eicke Latz
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 10, pp. 610-621
Closed Access | Times Cited: 650

Inflammasomes in neuroinflammatory and neurodegenerative diseases
Sofie Voet, Sahana Srinivasan, Mohamed Lamkanfi, et al.
EMBO Molecular Medicine (2019) Vol. 11, Iss. 6
Open Access | Times Cited: 613

NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
Limin Song, Lei Pei, Shanglong Yao, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 392

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis
Panayiota Petrou, Yaël Gothelf, Zohar Argov, et al.
JAMA Neurology (2016) Vol. 73, Iss. 3, pp. 337-337
Open Access | Times Cited: 280

Focus on the Role of NLRP3 Inflammasome in Diseases
Roberta Fusco, Rosalba Siracusa, Tiziana Genovese, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4223-4223
Open Access | Times Cited: 230

NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model
Wenjun Su, Yi Zhang, Ying Chen, et al.
Behavioural Brain Research (2017) Vol. 322, pp. 1-8
Closed Access | Times Cited: 191

The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Vandana Deora, John D. Lee, Eduardo A. Albornoz, et al.
Glia (2019) Vol. 68, Iss. 2, pp. 407-421
Closed Access | Times Cited: 163

Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases
Anguo Wu, Xiaogang Zhou, Gan Qiao, et al.
Ageing Research Reviews (2020) Vol. 65, pp. 101202-101202
Closed Access | Times Cited: 157

Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Y. Rajesh, Thirumala‐Devi Kanneganti
Cells (2022) Vol. 11, Iss. 12, pp. 1885-1885
Open Access | Times Cited: 150

Neurodegenerative Disease and the NLRP3 Inflammasome
Jonathan Holbrook, Heledd Jarosz-Griffiths, Emily A. Caseley, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 149

The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44

Inflammasomes in neurological disorders — mechanisms and therapeutic potential
Kishore Aravind Ravichandran, Michael T. Heneka
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 67-83
Closed Access | Times Cited: 37

Role of pyroptosis in the pathogenesis of various neurological diseases
Abiola Oladapo, Thomas L. Jackson, Jueliet Menolascino, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 428-446
Closed Access | Times Cited: 29

Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Caterina Peggion, Tito Calì, Marisa Brini
Antioxidants (2024) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 28

Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis
Dietmar Rudolf Thal, Klara Gawor, Sebastiaan Moonen
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Closed Access | Times Cited: 22

Immunotherapy for depression: Recent insights and future targets
Ying Bai, Yang Cai, Di Chang, et al.
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108624-108624
Closed Access | Times Cited: 19

Inflammasomes link vascular disease with neuroinflammation and brain disorders
Nikolett Lénárt, David Brough, Ádám Dénes
Journal of Cerebral Blood Flow & Metabolism (2016) Vol. 36, Iss. 10, pp. 1668-1685
Open Access | Times Cited: 154

Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson’s Disease via Regulating miR-7/NLRP3 Pathway
Bingqing Cao, Tao Wang, Qiumin Qu, et al.
Neuroscience (2018) Vol. 388, pp. 118-127
Closed Access | Times Cited: 143

Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop
François Mouton‐Liger, Thibault Rosazza, Julia E. Sepúlveda-Díaz, et al.
Glia (2018) Vol. 66, Iss. 8, pp. 1736-1751
Open Access | Times Cited: 133

The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling
Jing Qiu, Min Wang, Jun Zhang, et al.
International Immunopharmacology (2016) Vol. 40, pp. 492-500
Closed Access | Times Cited: 130

Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS
Junghee Lee, Seung Jae Hyeon, Hyeonjoo Im, et al.
Experimental Neurobiology (2016) Vol. 25, Iss. 5, pp. 233-240
Open Access | Times Cited: 130

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
Gerwyn Morris, Adam J. Walker, Michael Berk, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 7, pp. 5767-5786
Open Access | Times Cited: 125

Page 1 - Next Page

Scroll to top